semaglutide and dopamine GLP-1 receptor agonist reduces appetite while increasing reward signaling tirzepatide with alcohol Tirzepatide attenuates

WASHINGTON The Biden administration announced Tuesday its reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the long term

Additionally, it can be used in patients with established cardiovascular disease to reduce the risk of major cardiovascular events

Understanding DoD policy, fitness standards, and how genetic predispositions influence medication tolerance can help guide informed conversations with military medical providers about s

A study published in JAMA Psychiatry

PlexusDx explains what happens physiologically, when to reschedule your injection, and strategies to maintain consistency with your personalized GLP-1 therapy plan

Dan Monahan will serve in the role as the drug goes through Phase III trials.